Literature DB >> 28153197

Peritoneal Membrane Preservation.

M Auxiliadora Bajo1, Gloria Del Peso2, Isaac Teitelbaum3.   

Abstract

Peritoneal dialysis (PD) is a successfully used method for renal replacement therapy. However, long-term PD may be associated with peritoneal fibrosis and ultrafiltration failure. The key factors linked to their appearance are repeated episodes of inflammation associated with peritonitis and long-term exposure to bioincompatible PD fluids. Different strategies have been proposed to preserve the peritoneal membrane. This article reviews the functional and structural alterations related to PD and strategies whereby we may prevent them to preserve the peritoneal membrane. The use of new, more biocompatible, PD solutions is promising, although further morphologic studies in patients using these solutions are needed. Blockade of the renin-angiotensin-aldosterone system appears to be efficacious and strongly should be considered. Other agents have been proven in experimental studies, but most of them have not yet been tested appropriately in human beings.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Peritoneal dialysis; peritoneal fibrosis; peritoneal membrane; preventive measures; therapeutic interventions

Mesh:

Substances:

Year:  2017        PMID: 28153197     DOI: 10.1016/j.semnephrol.2016.10.009

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  8 in total

Review 1.  Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis.

Authors:  Zhen Zhang; Na Jiang; Zhaohui Ni
Journal:  Front Med       Date:  2017-08-08       Impact factor: 4.592

Review 2.  Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis.

Authors:  Valentina Masola; Mario Bonomini; Silvio Borrelli; Lorenzo Di Liberato; Luigi Vecchi; Maurizio Onisto; Giovanni Gambaro; Roberto Palumbo; Arduino Arduini
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

3.  Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists.

Authors:  Marta Ossorio; Virginia Martínez; Maria-Auxiliadora Bajo; Gloria Del Peso; Maria-José Castro; Sara Romero; Rafael Selgas; Teresa Bellón
Journal:  Biomed Res Int       Date:  2018-04-04       Impact factor: 3.411

Review 4.  Experimental models in peritoneal dialysis (Review).

Authors:  Bo Yang; Mengmeng Wang; Xue Tong; Ghada Ankawi; Lin Sun; Hongtao Yang
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

5.  A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience.

Authors:  Carmela Rago; Teresa Lombardi; Giorgia Di Fulvio; Lorenzo Di Liberato; Arduino Arduini; José C Divino-Filho; Mario Bonomini
Journal:  Toxins (Basel)       Date:  2021-02-24       Impact factor: 4.546

6.  High intraperitoneal interleukin-6 levels predict ultrafiltration (UF) insufficiency in peritoneal dialysis patients: A prospective cohort study.

Authors:  Qianhui Song; Xiaoxiao Yang; Yuanyuan Shi; Hao Yan; Zanzhe Yu; Zhenyuan Li; Jiangzi Yuan; Zhaohui Ni; Leyi Gu; Wei Fang
Journal:  Front Med (Lausanne)       Date:  2022-08-10

Review 7.  Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis.

Authors:  Mark Lambie; Mario Bonomini; Simon J Davies; Domenico Accili; Arduino Arduini; Victor Zammit
Journal:  Trends Endocrinol Metab       Date:  2021-07-12       Impact factor: 10.586

Review 8.  Proteomic Research in Peritoneal Dialysis.

Authors:  Mario Bonomini; Francesc E Borras; Maribel Troya-Saborido; Laura Carreras-Planella; Lorenzo Di Liberato; Arduino Arduini
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.